13 August 2021

GSK Stockmann advises Munich Hotel Partners on the acquisition and rebranding of Swissôtel Basel

GSK Stockmann advised Munich Hotel Partners GmbH (MHP) on the acquisition of the former Swissôtel Basel. MHP acquired the building in cooperation with US private equity company H.I.G Capital and concluded a long-term management agreement regarding the hotel operations as part of the joint venture, which was set up in Luxembourg. Furthermore, GSK Stockmann advised MHP on the franchise and all related agreements with Marriott International.

The former Swissôtel Basel will be run in the future as Marriott Hotel Basel. The hotel’s rebranding to the premium brand Marriott will take place after an extensive refurbishment in the coming months. By acquiring a minority stake in the property, MHP is co-investing in the hotel real estate market for the first time, and is thus expanding its business model. The parties agreed not to disclose the purchasing price.

A GSK Stockmann team led by partners Stefan J. Schlapka (Munich) and Philipp Mössner (Luxembourg) advised on the deal. The seamless cooperation between the teams in Germany and Luxembourg has proven again to be advantageous for German clients investing through Luxembourg.

Advisers of Munich Hotel Partners GmbH:

GSK Stockmann: Stefan J. Schlapka, Philipp Mössner (both Real estate transactions, both lead); Associate: Kate Yu Rao (Corporate)


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Dr. Philipp Mössner, LL.M.


+352 271802-40


Kate Rao, LL.M.

Senior Associate

+352 271802-54


© GSK Stockmann 2022